Stock overview
Takeda Pharmaceutical Co. Ltd.
Explore the company, reported ownership, price history, and available source evidence.
TAKEDA PHARMACEUTICAL CO LTD (TAK) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $18.51
- · TAK
- Tracked holders
- 2 funds
- Latest available 13F per fund
TAK · USD
Price
$18.51
+$0.88
(+4.99%)
over selected range
Close · Sep 29, 2026
Market closed
32 stored daily closes
$18.51
Sep 29, 2026
- Range low
- $17.38
- Range high
- $19.05
- Observations
- 32
- Session date
- Sep 29, 2026
Aug 14, 2026–Sep 29, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Renaissance Technologies largest tracked holder Q2 2026 · filed Aug 13, 2026 · SEC filing | −14% 26'Q2 | $41,165,040 | 0.06% |
| Tudor Investment Corp position history Q2 2026 · filed Aug 14, 2026 · SEC filing | Newly reported 26'Q2 | $1,605,388 | 0% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market